Neuroscience nursing tackles mysteries of the brain – Nurse.com

Researchers have discovered in recent years early and sometimes aggressive treatment of stroke and traumatic brain injury can preserve function and independence for many patients who in the past had no choice but to live with debilitating disability.

Anna Ver Hage, RN

It became part of the guidelines to actually remove clots from large vessels versus saying theres not much we can do after a stroke, said Anna Ver Hage, MSN, RN, AGACNP-BC, CNRN, a speaker for the Relias Neuroscience Nursing Certification Review, which prepares nurses for the exam to become certified as Certified Neurosciences Registered Nurse (CNRN).

And today more patients are candidates for advanced treatments.

In January 2018, an updated guideline for acute stroke management published in the journal Stroke recommended extending the timeline for mechanical endovascular thrombectomy from the 2013 guideline recommendation of 6 hours post stroke to up to 24 hours after stroke onset in some patients.

Advances in traumatic brain injury include the use of new medications to try and stimulate and awaken patients, greatly improving outcomes in some cases. And technology is rapidly changing. Todays MRIs are capable of imaging specific brain tracts.

To see what damage was done and what the prognosis is going forward is a huge help in the acute phase, said Ver Hage, who is a stroke nurse practitioner who works at Banner Desert Medical Center in Mesa, Ariz.

Years ago, nurses would share with patients and families what staff thought might happen.

With advanced imaging, we can give them a lot better idea about what to expect and what rehab is going to be needed going forward, she said.

Tracey Anderson, CNRN

Neuroscience nursing stands out among other specialties because the diagnoses are life-changing for many patients. Care goes beyond saving a life and can include helping people get back to who they were before an injury from trauma, stroke or brain tumor, said Tracey Anderson, CNRN, FNP-BC, ACNP-BC, a neurosurgery nurse practitioner who works in a private practice covering four hospitals in Southern California.

Its sort of shepherding them through their journey whether thats back to wellness or making the most of the time they have left, said Anderson, who serves on the certification board for the American Board of Neuroscience Nursing.

The need for neuroscience nursing is growing as the population ages, according to Ver Hage.

We are treating neurologic illnesses and injuries more aggressively than we used to, and I think that has increased substantially the number of nurses that are needed that have neuro expertise, Anderson said.

A lot of nurses are very uncomfortable with neuro because they just dont feel like they know how to assess the patient. Theyre afraid theyre going to miss something and ultimately they avoid it, she said. They go into anything but neuro. Its a specialty in terms of a focus where either you love it or hate it. Theres not a lot of middle ground and the people that love it never leave.

Many hospitals and health systems are achieving higher levels of stroke care, becoming primary stroke centers, comprehensive stroke centers and more, resulting in the need for more experienced and specialized staff.

There is a big push in those hospitals to get their nurses certified, Ver Hage said. Thats great because you cant run a specialty center without specialty nurses.

Its one thing to focus on the expertise of physicians and having a neurologist or vascular surgeon on staff. Its another to focus on the specialization of nurses because the vascular surgeon or neurosurgeon is not there at the bedside evaluating patients 24 hours a day as the nurses are, according to Ver Hage.

But learning the specialty isnt easy. Its something nurses generally transition into, according to Ver Hage.

Neuroscience nursing is not something that you necessarily spend a lot of time on in school, so your training does not really focus on the management of these patients, she said.

Learning about the intricacies of the brain and how injuries to different parts of the brain cause very different symptoms and disabilities is a complicated process. Its not like assessing a broken bone, in which healing time and functional outcomes might be pretty clear cut.

With brain injuries we dont have that, Ver Have said. Its very specific and its very difficult to learn that without a lot of training and a lot of experience.

Thats where certification and specific continuing education come in, according to Ver Hage.

Nurses who are certified have taken training courses and have been exposed to these patients on a daily basis, she said.

Because of that training, a neuroscience nurse might assess a patient with dizziness, for example, differently than a medical nurse.

The medical nurse might not think much of it and suggest the patient lie down. The neuroscience nurse is going to consider cerebellar stroke or some other brain injury type and look further into the cause.

By obtaining a specialty certification in neuroscience nursing, RNs show their commitment to the patient population under their care. It raises nurses professional status by demonstrating a level of expertise that others may not have, according to Anderson.

Neuroscience nursing is for the nurse who is really looking to make a difference, according to Anderson, not just in patients lives, but also in families lives.

Patients look to you as the expert and you need to be the expert, Anderson said. Thats where certification and continuing education becomes critical because if you dont know and you arent an expert how in the world are you going to help them?

Learn more about our Neuroscience Nursing Certification Review course, with class session starting several times throughout the year.

Read more here:
Neuroscience nursing tackles mysteries of the brain - Nurse.com

Aspen Neuroscience Receives $6.5M for Parkinson’s Stem Cell Therapy – Parkinson’s News Today

Aspen Neuroscience, a new biotech company, has raised $6.5 million to develop cell therapies for Parkinsons disease using patients own cells.

The company was co-founded by renowned stem cell scientists Jeanne F. Loring, PhD, and Andres Bratt-Leal, PhD, and initially supported by Summit for Stem Cell, a non-profit organization that provides a variety of services for Parkinsons patients.

Parkinsons hallmark motor symptomsinclude tremor, slowness of movement (bradykinesia), stiffness (rigidity), uncontrollable movements (dyskinesia), and poor balance.

As the disease progresses, patients typically need to gradually increase their dopaminergic therapeutic dose for maximum benefit. Even after that they might sometimes experience reappearance or worsening of symptoms due to diminishing effects of dopaminergic therapy, known was off periods.

Importantly, dopaminergic therapy is delivered to areas of the brain other than the striatum, a key motor control region severely affected in Parkinsons disease. Because of the therapys off-target behavior, patients also may experience side effects such as hallucinations or cognitive impairment.

Aspen wants to combine its expertise in stem cell biology, genomics and neurology and develop the first autologous (self) stem cell-based therapy for Parkinsons disease.

In this type of cell therapy, a patients own cells (usually skin cells) are reprogrammed back into a stem cell-like state, which allows the development of an unlimited source of almost any type of human cell needed, including dopamine-producing neurons, which are those mainly affected by this disorder.

Because these cells are derived from patients, they do not carry the risk of being rejected once re-implanted, eliminating the need for immunosuppressive complementary therapies, which carry serious side effects such as infections and possibly limiting therapeutic potential.

In theory, replacing lost dopaminergic neurons with new stem cell-derived dopamine-producing ones could potentially ease or reverse motor symptoms associated with the disease.

Aspen is developing a restorative, disease modifying autologous neuron therapy for people suffering from Parkinsons disease, Howard J. Federoff, MD, PhD, Aspens CEO, said in a press release.

We are fortunate to have such a high-caliber scientific and medical leadership team to make our treatments a reality. Our cell replacement therapy, which originated in the laboratory of Dr. Jeanne Loring and was later supported by Summit for Stem Cell and its President, Ms. Jenifer Raub, has the potential to release dopamine and reconstruct neural networks where no disease-modifying therapies exist, Federoff said.

The companys lead product (ANPD001) is undergoing investigational new drug (IND)-enabling studies for the treatment of sporadic Parkinsons disease. Aspen experts also are developing a gene-editing treatment (ANPD002) for familial forms of Parkinsons, starting with the most common genetic variant in the GBAgene, which provides instructions to make the enzyme beta-glucocerebrosidase.

The new seed funding round was led by Domain Associates and Axon Ventures, with additional participation from Alexandria Venture Investments, Arch Venture Partners, OrbiMed and Section 32, according to the press release.

With over three years of experience in the medical communications business, Catarina holds a BSc. in Biomedical Sciences and a MSc. in Neurosciences. Apart from writing, she has been involved in patient-oriented translational and clinical research.

Total Posts: 208

Ana holds a PhD in Immunology from the University of Lisbon and worked as a postdoctoral researcher at Instituto de Medicina Molecular (iMM) in Lisbon, Portugal. She graduated with a BSc in Genetics from the University of Newcastle and received a Masters in Biomolecular Archaeology from the University of Manchester, England. After leaving the lab to pursue a career in Science Communication, she served as the Director of Science Communication at iMM.

See the original post:
Aspen Neuroscience Receives $6.5M for Parkinson's Stem Cell Therapy - Parkinson's News Today

New applied cognitive neuroscience course offered at RIT – RIT University News Services

RIT will use a substantial gift of real estate in Penfield to expand the universitys research and educational offerings in ecology, agriculture, sustainability and other fields. Amy Leenhouts Tait and Robert C. Tait have gifted to the university their 177-acre property, which will be dedicated as the Tait Preserve of RIT.

Read the original post:
New applied cognitive neuroscience course offered at RIT - RIT University News Services

International Peace Prize awarded to Ascension St. Mary’s executive director – Midland Daily News

Gary L. Dunbar, executive director of the Field Neurosciences Institute, part of Ascension St. Mary's, was recently presented with the Gusi Peace Prize International Award.

Dr. Dunbar recently traveled to Manila, Philippines to accept this honor at the Gusi Peace Prize International 20th Annual Awards Night.

The Gusi Peace Prize award is given by the Gusi Peace Prize Foundation to recognize individuals and organizations who contribute to global peace and progress through a wide variety of fields. Dunbar was one of 18 international recipients selected for the award and chosen because of his global contributions in both the educational and the research domains of neuroscience. Similarly, his contributions in research, especially for developing new strategies for treating damage to the nervous system, including transplantation of genetically altered adult stem cells as a potential therapy for injury to the brain and spinal cord as well as neurological deficits in Huntington's, Parkinson's and Alzheimer's diseases, has earned international recognition and a prominent leadership role in the American Society for Neural Therapy and Repair.

"I felt both honored and humbled to be selected for the Gusi Peace Prize, especially after meeting and hearing, first-hand, what the other 2019 Gusi Laureates have accomplished in the context of helping others, which was humbling to me," shared Dunbar. "The prize is given to those whose efforts have provided significant improvements to the lives of others through education, research, politics, and/or the arts, along with a strong commitment to humanitarian commitments, so I felt deeply honored to be included in this group of people."

Dunbar has been the executive director for the Field Neurosciences Institute since 2008. Martha Ann Joseph, Chair of the institute's board of directors, was thrilled to hear that Dunbar was a recipient of the Gusi Peace Prize International Award.

"(Field Neurosciences Institute) is blessed to have Dr. Dunbar as our executive director for the past 11 years as he has always embraced the mission of the organization, to help others in terms of preventing brain injury and searching for cures for neurological problems emanating from trauma and disease to the nervous system," Joseph said.

"Dr. Dunbar embodies the very premise of the Gusi award in attaining peace and dignity for fellow humans by his tireless devotion to finding new ways to treat a variety of neurological disorders and for his dedicated efforts in educating the next generation of neuroscientists, physicians, and health-care providers at the highest level," added E. Malcolm Field, Field Neurosciences Institute director.

Presently, Dunbar holds the John G. Kulhavi Professorship in Neuroscience, as well as the E. Malcolm Field Endowed Chair in Neuroscience at CMU.

The Gusi Peace Prize was founded by the Honorable Ambassador Barry Gusi, to honor and continue the work of his late father, Captain Gemeniano Javier Gusi, who fought against Japanese oppression during World War II and later championed human rights in the Philippines. For 20 years, the Gusi Peace Prize Award has been awarded to prominent individuals from all over the world who have made significant contributions to the betterment of humankind.

See the article here:
International Peace Prize awarded to Ascension St. Mary's executive director - Midland Daily News

How to train your brain to be more productive – SmartCompany.com.au

How many productivity hacks have you tried this year?

Whether its a new app, morning workout, green smoothie or an inspiring podcast, there are a myriad of things that have been touted to improve our efficiency each day. But something you may not have considered is taking advantage of neuroscience to boost your productivity.

Its not a new concept; its been used in high-performing roles including by the military and Olympic athletes for years. But now the corporate world is starting to pay attention and looking into how we can rewire our brains to be more productive, specifically with neuroplasticity.

Neuroplasticity was first discovered in the 1940s by Donald Hebb and describes how our brains change in response to repeated experience.

The brain is designed to learn, grow and rewire throughout our lives, based on different experiences, and it has various neural pathways connecting different responses. For instance, when you eat a food you love, you respond with happiness, while being stuck in traffic might make you respond with anger. These behaviours are learned over time and science has shown we can rewire our brains to change these automatic responses and regulate our emotions with some training and practice. By taking advantage of your brains neuroplasticity, you can create new habits to help you be more productive.

Stress can be a huge enemy of efficiency and productivity. Many of us have experienced stress that temporarily inhibits our ability to think clearly, but you may not know just how much it affects your brain. Being in a state of stress forces the blood in the brain to be redirected away from our prefrontal cortex, and then our amygdala and adrenal glands start firing. This effectively puts us into fight or flight mode, dropping our intelligence and increasing our motor skills instead. These days, most stressful situations require us to use our minds rather than our bodies, so being able to change your brains response will help you manage stress more effectively.

As a first step you need to be aware of exactly what causes a stress reaction, so you can train yourself to react differently. Once this is clear, you can interrupt or redirect your brains response when faced with a trigger and replace it with a positive response. Imagine yourself in the stressful situation and follow it with happiness, laughter or calmness. You will need to repeat this hundreds of times for it to build a new pathway in your brain. But after some practice, you will be able to stop the stress before it affects you negatively, helping you be more productive.

No matter how hard we try, no one can be 100% productive, 100% of the time. We all have states of being more productive, whether its at a certain time of the day, working in a specific location, or listening to music. Learn your own habits and become self-aware about your productivity patterns.

A great way to expand your self-awareness is to try journaling, which creates a process of regular self-reflection. Keeping a journal helps you become more conscious of your strengths and weaknesses. Once you know your own behaviours, you can use it as an opportunity to enhance productivity.

Aside from these broader patterns, its important to be aware of your thoughts and emotions when working on a task that requires your focus. Being mindful involves being present in the moment, and tools such as slowing your breathing and focusing on something tangible that you can hold may help.

Mindfulness helps you be aware of yourself without any judgment, so you can notice your thoughts and remove any negative emotions. You can then focus on the task and what needs to be done next, helping you stay productive.

Meditation is a powerful tool to help you notice and observe your thoughts and behaviours, so you can then choose to change your responses. Meditating has been proven to change brain structure, particularly for those who practise it over a long period of time. This is because meditation increases the level of oxygen and nourishment in different areas of the brain, making it easier to sustain attention and redirect focus, and therefore better manage your emotions and be more productive.

Meditation rewires and trains your brain to be more disciplined and less stressed, with research showingjust five minutes each day can make a difference.

You might think you dont have the time to learn something new, but using your brain in a new way improves your cognition, making you more switched on and, in turn, more productive.

It doesnt need to be work related either, it can be something fun! You can learn a new language, play a new sport or even just read a new book each week. If you want it to be job related, you can organise company training or try an online course. Whatever you choose to do, it will rewire your brain and improve cognitive function. Keeping the brain fit will help you improve your efficiency both at work and at home.

NOW READ:How neuroscience can improve your business marketing today

NOW READ:The entrepreneurs making it their business to improve your wellbeing despite the hype

More here:
How to train your brain to be more productive - SmartCompany.com.au

How to bring precision medicine into the doctor’s office – World Economic Forum

Are you one of the 26 million people who have experienced genetic testing by companies such as 23andMe or Ancestry? These companies promise to reveal what your genes say about your health and ancestry. Genes are, indeed, the instruction book containing the code that makes you a unique human being. This specific code which you inherit from your parents is what makes you, you.

The genetic coding system works amazingly well, but like all systems, occasionally things dont go as planned. You may inherit a gene that increases your chance of developing a health condition and sometimes the code develops an error causing you to have a devastating disease.

If genetic testing is so powerful in analysing and understanding your health, why cant you just as easily have this same genetic information inform your care at the doctors office? To answer this question, lets first look at the field of using genetic information to drive your healthcare (often referred to as precision or personalized medicine).

Across the globe, researchers devote enormous amounts of time and effort to understand how human genes impact health and billions of dollars are invested. The knowledge of what impact specific genes have on our health has increased tremendously and continues to do so at an amazing pace. Our increased understanding of genes, and how they affect our health, is driving novel methods to halt diseases and new ways of thinking about how medications can be developed to treat diseases.

Precision medicine is a growth area

With all this money and effort being expended, why isnt the use of your genetic information a standard part of your medical care? As the Kaiser Permanente Fellow to the World Economic Forums Precision Medicine Team, I recently had the opportunity to interview leaders from every aspect of Precision Medicine to understand the barriers preventing genetic testing from becoming a standard part of your healthcare.

Those with whom I spoke included insurance companies who pay for the tests, doctors who use and interpret them, genetic counsellors who help you understand test results, diagnostic companies which develop testing, government healthcare regulators, researchers making astonishing discoveries and healthcare organizations who are determining how best to deploy genetic testing.

These interviews suggest that the science behind genetic testing and the knowledge of how genes impact health is far ahead of our ability to make full use of this information in healthcare. Moving genetic testing into your doctors office requires a complex set of technologies, processes, knowledge and payments. Though many of the barriers inhibiting this movement were unique and complex, there were some consistent and common themes:

1. The limited expertise in genetics within healthcare systems. The need for education of healthcare providers as well as the public was regularly highlighted. The use of genetics in healthcare requires specialized knowledge that is outside the expertise of most doctors. Healthcare providers simply dont have time to study this new and rapidly changing information as their hands are full just keeping up with the latest trends and findings in their specialities. Additionally, education on genetics in healthcare is needed for the public. As one person interviewed said: The public watches CSI and thinks the use of DNA and genetics is black and white; using genetics in healthcare is rarely black and white

2. The lack of sufficient genetic counsellors. Genetic counsellors are often used to engage patients prior to testing and after results have been received, providing them with the detailed and nuanced information required for many of these tests. They also support doctors when they need assistance in making decisions about genetic testing and understanding the test results.

3. To successfully embed genetics into your care, doctors need the workflows for genetic testing (receiving results and understanding the impact on their care plans) to become a seamless part of their work. Clinical decision support software for genetics should alert the healthcare provider when genetic testing is merited with a patient, based on information the provider has entered during their examination. The software should then provide a list of appropriate tests and an explanation of why one might be used over another. After doctors order the test, they believe is most appropriate, the system should inform them of the results in clear, easily understandable language. The results should inform the doctor if the care plan for this patient should be modified (with suggestions for how the care should change).

4. Coverage of payments for genetic testing. If such tests are not paid for by insurers or government healthcare agencies (the payers), doctors simply wont order them. In the US and many other countries, there is patchwork coverage for genetic testing. Some tests are covered under specific circumstances, but many are not covered at all. The major reason cited by the payers for not covering genetic testing is a lack of evidence of clinical efficacy. In other words, do these tests provide actionable information, that your doctor can use to ensure better health outcomes? Until the payers see sufficient evidence of clinical efficacy, they will be hesitant to pay for many types of genetic testing. Doctors are concerned about the same thing, according to my research. They want to see the use of these tests in large populations, so they can determine that there is a benefit to using them.

Using your genetic information in healthcare is much more complex than taking a direct-to-consumer genetic test such as those offered by 23andMe. Healthcare is a multifaceted system and doctors already have too much on their plate. As such, there must be sufficient proof that the use of genetic testing will result in better health outcomes for the populations these clinicians serve before it's introduced into this setting.

We cannot hesitate in the face of the above complexities. As I completed the interviews which revealed these barriers, I stumbled across a journal article on this very subject. Written by a prominent group of doctors and researchers from government and leading universities in 2013, it highlights these same barriers and that virtually no progress has been made in the ensuing seven years. This is why I am focusing my fellowship at the World Economic Forum on a new project called Moving Genomics to the Clinic. Taking advantage of the multistakeholder platform of the Forum, the project will quicken the pace of tackling these barriers so that the use of genetic information can become a standard part of your healthcare experience.

License and Republishing

World Economic Forum articles may be republished in accordance with our Terms of Use.

Written by

Arthur Hermann, Fellow, Precision Medicine, World Economic Forum

The views expressed in this article are those of the author alone and not the World Economic Forum.

Continue reading here:
How to bring precision medicine into the doctor's office - World Economic Forum

Why are female test subjects still being excluded from exercise research? – The Globe and Mail

The criticism from an anonymous peer reviewer caught Matthew Heath by surprise.

The University of Western Ontario kinesiology professor had submitted a study on the cognitive benefits of exercise, involving seven men and five women. But the inclusion of women, the reviewer argued, was a mistake, due to cognitive and physiological differences in the menstrual cycle. To avoid this complication, women should have been excluded from the study.

Heath disagreed so he decided to investigate this claim. In a study published last month, Heath, undergraduate research student Kennedy Dirk and kinesiology professor Glen Belfry tested the effects of exercise on cognition in women at different stages of their menstrual cycles.

Story continues below advertisement

The results, which appear in the journal Medicine & Science in Sports & Exercise, found no differences linked to hormonal fluctuations. Thats good news for Heath (whose original study was eventually published despite the reviewers objections), but it highlights a continuing challenge in exercise research: An overwhelming number of studies either omit women completely or make the mistake of assuming that women are, as physiologist Stacy Sims puts it, simply small men.

The new study involved 15 female subjects who did 20 minutes of moderate cycling, preceded and followed by a test measuring executive function, which involves cognitive processes such as working memory and attentional control. They repeated this process once during the early follicular phase of their menstrual cycle, when estrogen and progesterone levels are at their lowest, and once during the midluteal phase, when theyre elevated. Performance on the cognitive test increased after exercise by the same amount in both tests.

The idea that hormonal changes might influence cognitive function isnt totally unfounded, Heath points out. A review of the relevant literature by Swedish researchers in 2014 suggested that emotional processing may change across the menstrual cycle, but concluded that such differences were small and difficult to replicate hardly a good reason to exclude women from studies of this type.

That doesnt, however, mean that men and women are interchangeable in all exercise studies. On average, men tend to be bigger and heavier than women, have different distributions of muscle-fibre type and patterns of fat storage, and respond to physical stresses in slightly different ways.

For example, a study published this month in Sports Medicine by University of Calgary researchers Candela Diaz-Canestro and David Montero analyzed previous research comparing how men and women respond to endurance training. For a given level of training, they found that men seem to get a slightly bigger boost in VO2max, a measure of aerobic fitness. On the other hand, women seemed to get a greater boost in lifespan from increasing their VO2max by a given amount.

These differences are subtle, but they do exist. And the solution, Heath and others argue, isnt to exclude women from studies its to include them, and where relevant analyze the results separately to look for differences.

The U.S. National Institutes of Health, the worlds largest funder of biomedical research, has mandated the inclusion of both men and women in clinical trials since 1994, points out Brock University doctoral researcher Kate Wickham. But attitudes such as those of Heaths anonymous reviewer remain surprisingly common.

Story continues below advertisement

When Wickham set out to explore the performance-boosting effects of nitrate-rich beet juice during her masters degree at the University of Guelph, she found more than 100 studies on the topic that features all-male subject populations. In comparison, there were just seven all-female studies.

Based on the extremely limited data available, it seems that women may actually get a bigger endurance boost from beet juice than men. But its not clear whether that reflects some subtle difference in physiology or whether its simply a result of women typically being smaller than men (and thus getting a higher nitrate dose from a bottle of beet juice), or the fact that women tend to eat more nitrate-rich foods such as spinach and arugula.

The bottom line is that we dont know the answer to these and many other questions and we wont until research that includes both men and women is not just accepted but expected.

Alex Hutchinson is the author of Endure: Mind, Body, and the Curiously Elastic Limits of Human Performance. Follow him on Twitter @sweatscience.

Live your best. We have a daily Life & Arts newsletter, providing you with our latest stories on health, travel, food and culture. Sign up today.

Follow this link:
Why are female test subjects still being excluded from exercise research? - The Globe and Mail

Air Pollution Is Breaking Our Hearts: Particulate Matter Leads to Thousands of Deaths per Year – SciTechDaily

Air pollution is associated with detrimental effects on human health, including increased risk of heart disease and stroke. Research published today (December 15, 2019) in The Journal of Physiology by researchers at The University of Manchester shows that the knowledge we have about how pollution harms the hearts of marine species can be applied to humans, as the underlying mechanisms are similar. In other words, knowledge gained from the marine ecosystem might help protect the climate and health of our planet, whilst also helping human health.

Around 11,000 coronary heart disease and stroke deaths in the UK each year are attributable to air pollution, specifically due to particulate matter (PM), or small particles in the air that cause health problems. PM2.5 is one of the finest and most dangerous type of PM, is a compound for which the UK has failed to meet EU limits.

Researchers of this study looked across all vertebrates and particularly focused on a set of compounds that binds to the surface of PM, called polycyclic aromatic hydrocarbons (PAH) as the amount of PAH on PM is associated with the detrimental affect air pollution has on the heart.

While air pollution is known to be dangerous to humans, it actually only became a widely-researched topic in the past five years or so. In marine species, however, the mechanism of how PAH pollution causes heart problems is well understood.

Studies after the 1999 Exxon Valdez oil spill showed that the ecosystem still has not recovered 20 years on. In 2010, research on fish after the Deepwater Horizon oil spill, which released large quantities of PAHs into the marine environment, showed that the hearts ability to contract was impaired.

Dr. Holly Shiels, senior author on the study, from The University of Manchester said:

Pollution affects all of us living on Planet Earth. Due to the conserved nature of cardiac function amongst animals, fish exposed to PAH from oil spills can serve as indicators, providing significant insights into the human health impacts of PAHs and PM air pollution.

Dr. Jeremy Pearson, Associate Medical Director at the British Heart Foundation, which partly funded the research presented in this review, commented:

We know that air pollution can have a hugely damaging effect on heart and circulatory health, and this review summarises mechanisms potentially contributing to impaired heart function. Reducing air pollution is crucial to protecting our heart health, which is why the BHF is calling on the next Government to commit to reducing air pollution to within WHO limits.

Reference: Polyaromatic hydrocarbons in pollution: A heartbreaking matter by C. R. Marris, S. N. Kompella, M. R. Miller, J. P. Incardona, F. Brette, J. C. Hancox, E. Srhus and H. A. Shiels, 15 December 2019, The Journal of Physiology.DOI: 10.1113/JP278885

Continued here:
Air Pollution Is Breaking Our Hearts: Particulate Matter Leads to Thousands of Deaths per Year - SciTechDaily

Research at the ends of the earth – AAMC

Think biomedical research and you may envision test tubes, microscopes, and rows of petri dishes. But for some scientists, conducting research instead means strapping on scuba gear, scaling the slopes of Mount Everest, joining foraging tribes on a South Asian hillside, or embarking on other equally remote adventures. Sometimes, the work involved is uncomfortable or downright dangerous. But these researchers say it also can be exhilarating to advance medical knowledge in ways that arent feasible without such severe conditions or far-flung treks.

Here are profiles of several scientists who went to extremes, not just for a change in scenery, but because as Martin Cetron, MD, an Emory University School of Medicine professor and supervisor at the Centers for Disease Control and Prevention (CDC), says Thats where you had to go to do the work.

It was a simple question. During a presentation, Richard Moon, MD, a professor of anesthesiology and medicine at Duke University School of Medicine, was asked, Why study people at high altitudes?

Moon, who also directs Dukes Hyperbaric Center, recited a boilerplate explanation: At high altitudes, blood oxygen concentrations are often far below normal. This potentially dangerous condition, called hypoxia, also crops up in medical contexts from anesthesiology to critical care.

As Moon sat down, a colleague leaned over to critique his answer. What you should have said is that [at high altitudes] people expose themselves voluntarily to degrees of hypoxia that no human experimentation committee would ever allow.

That, Moon concedes, was right. Im sure if I went to the Duke Institutional Review Board and proposed lowering peoples oxygen saturation to below 60%, it would never be approved. But on our Everest trek we found that people were at that level all the time.

In 2013 and again in 2017, Moon and several Duke colleagues took advantage of an opportunity to join Mount Everest hikes organized by British scientists, where they would study high-altitude trekkers under field conditions.

One of the questions that is very important clinically is how low can you go in blood oxygenation without causing serious damage, Moon explains.

During his recent trek, Moon asked fellow hikers to strap on a pulse oximeter a watch-like devicewith a probe that connects to the wearers finger or forehead so he could monitortheir oxygen saturation. He instantly had more subjects than he could stuff into a hyperbaric chamber.

Several hikers were treated for acute mountain sickness and altitude-related cerebral edema, but others suffered no serious problems. At the highest camp, at an altitude of more than 18,000 feet, Moon recorded his own lowest reading: below 60% oxygen saturation. Others recorded even lower readings, Moon noted, which, if seen in any of our hospital patients, would elicit panic. Now, he believes, low levels in some circumstances may not be as dangerous as once thought.

Also on Moon's agenda has been recruiting volunteers primarily mountaineering guides for a project with British investigators on epigenetic changes in people whose bodies adapt to the lower oxygen levels of high altitudes.

Imagine if we had a drug that could induce that adaptation, says Moon. If patients needing oxygen treatments could manage with lower levels, they might avoid some of the treatments risks, which include nerve, eye, and lung damage. For people who are in the ICU with lung failure, we wouldnt have to give them as much oxygen,he notes. "What a huge advance that would be.

To better understand how human physiology from brain function to the gut microbiome responds in a pressurized environment, Dominic DAgostino, PhD, dove 62 feet beneath the surface to an undersea laboratory called the Aquarius Reef Base, off Key Largo, Florida.

DAgostino is an associate professor of molecular pharmacology and physiology at the University of South Florida Morsani College of Medicine. A trained diver, his research interests include how to prevent oxygen toxicity seizures, which can occur when a person breathes concentrated oxygen. The seizures threaten patients undergoing hyperbaric therapy for such medical issues as decompression sickness and wounds that wont heal and they can be fatal.

As DAgostino dove deeper literally and figuratively into physiology in extreme environments, he met NASA workers who replicate the weightlessness of space by going under water. Those connections got him invited on a 2017 NEEMO (NASA Extreme Environment Mission Operations) mission to the Aquarius lab, which is run by Florida International University.

I was about jumping out of my skin and pinching myself. I wanted to incorporate as much science as possible into that mission, DAgostino says.

After strapping on scuba gear, the crew members swam down to Aquarius and popped up in a chamber where trapped air prevented the sea from rushing in. The air is more than twice as dense as at sea level, explains DAgostino. You feel it when youre breathing it, and you feel it when you talk.

For ten days, the crew followed a packed schedule. We would do about half the science inside the habitat and about half outside, DAgostino explains. Among his tasks was collecting data on pressure-related changes in sleep, skin microbiomes, metabolic markers, strength, and decision-making.

The work, which included studying their own bodies under demanding conditions, was worth the effort, DAgostino notes. I can say without reservation that the NASA NEEMO mission was the most intense, amazing experience of my life, he says. Its the only habitat really in the world that can allow us to do this kind of science.

One day, while studying the gut microbiome in rural tribes in Nepal, Aashish Jha, PhD, was apportioning human waste into glass vials. A villager expressed concern. She knew he had gone to college for many years. If we send our children to college, will they have to do something like this also? she asked.

But Jha, a post-doctoral researcher at the Stanford University School of Medicine, was delighted to spend many months collecting stool samples.

For the stint in 2016, Jha selected several tribes far from major roads and markets. All had been nomadic hunter-gatherers, but some had changed over time. The Tharu, for example, had developed agriculture about 300 years ago, and the Raji had begun farming more recently. The Chepang were the hardest to reach. Still foraging wild fruits and vegetables, they lived on a barren hill accessible only by four-wheel drive.

Because these tribes were exposed to similar bacteria in a close geographic area, and because their lifestyles diverged only recently, they provided very nice comparison groups to understand how the human gut microbiome deviates from a traditional foraging type as humans move closer and closer to agriculture, says Jha.

A stranger asking for human waste might be a difficult sell, but Jha worked with anthropologists and others who already had ties with the groups.

The concept of microscopic bugs in the digestive tract wasnt very difficult to explain. It wasnt that foreign a concept for people, because people in Nepal get helminth infections all the time, Jha says. Helminths are visible parasitic worms. So when we tell them there are little tiny bugs in their gut, they think of helminths.

Jha found that the villagers microbiomes lined up on a very nice gradient of microbial shift, with the foraging Chepang at one end and the agricultural Tharu at the other. Bacterial species common in foragers were scarce or nonexistent among farmers and vice-versa. Many of the bacteria found among the tribes were absent from the American microbiome, which is representative of people who rely on industrial agriculture.

Jha hopes that additional studies will clarify the possible role of missing bacteria in conditions such as irritable bowel syndrome, rheumatoid arthritis, and celiac disease that appear to be mediated by the microbiome.

A big question is what role the missing bacteria play. Whether they are medically relevant, we dont know, says Jha. That is the next step that we are exploring.

As a professor of emergency medicine at the University of Colorado School of Medicine, Ben Easter, MD, is, quite naturally, concerned about emergencies.

But the emergencies that most interest Easter will occur on Mars.

To help anticipate problems that humans could encounter on the red planet, Easter works at the Mars Desert Research Station, located in a barren stretch of Utah he describes as absolutely Martian. There he dons a spacesuit, communicates via a radio in his helmet, and leads students, physicians, and engineers in simulated life-and-death struggles on week-long missions. Since 2015, Easter has led a half-dozen courses at the station, which is run by the nonprofit Mars Society.

Ive always been interested in space, long before I ever wanted to be a doctor, he says.

The Mars crew lives in a habitat equipped with solar panels, a research dome for lab work, and electric vehicles for traveling outside. They periodically pull on spacesuits, sit patiently in a simulated airlock, and exit the station for extravehicular activities, such as collecting soil samples.

But sometimes someone often Easter suddenly comes sliding down a rocky outcrop feigning a broken limb and bearing a tear in his spacesuit thats gushing oxygen.

So the group has to find and isolate the leak and patch the leak to prevent the person from getting decompression sickness. In addition to taking care of the suit, they have to figure out how theyre going to evacuate their injured crew member back to the habitat, says Easter. The amazing thing is how much we were able to create scenarios where the crew really buy into their environment.

The Mars simulations provide a helpful supplement to Easters other work as a researcher at Johnson Space Center, where he uses mathematical models to anticipate extraterrestrial emergencies. But Easter most values the missions chance to educate and inspire.

Weve had some of our students and physicians significantly alter their careers to pursue work in space medicine or a space industry-related field, he says. Being able to put together a week-long course that people are really excited about and then give them that spark to change what theyre doing with their life and pursue something that they really enjoy, I think thats what Im most proud of.

Among his research efforts, Martin Cetron, MD, developed field tests in southern India for the early diagnosis of leprosy and collaborated with local teams in northeastern Brazil to uncover the source of a protozoan that was causing the sometimes fatal disease leishmaniasis.

Along the way, he contracted intestinal diseases, malaria, and schistosomiasis, which he calls a poignant reminder of the connection between field research and the patient experience.

But a bit of medical detective work for the CDC in Africas Lake Malawi in 1992 changed the course of his career.

I thought I was coming here for a two-year stint to learn more about parasitic infections from the worlds experts and would go back to an academic research and clinical career, he says.

Instead, he found himself solving mysterious instances of schistosomiasis, which is caused by a snail-based parasitic flatworm. The cases involved a complex, tangled story: After drought ravaged corn crops, desperate villagers turned malaria bed nets into fishing gear, and they then overfished a predator that usually reduces the snail population. Cetron ultimately discovered that 90% of village schoolchildren had been infected without anyone realizing.

He marvels at the irony that the intended public health intervention of bed nets to prevent hyperendemic malaria enabled the schistosomiasis epidemic. I was so dumbfounded that I spent the rest of my working life at CDC exploring the intersection of pathogens, hosts, human behavior, and the environment.

Cetron is now director of the CDC Division of Global Migration and Quarantine and an adjunct associate professor at the Emory University School of Medicine. His work involves overseeing several international efforts, including a project that detects disease outbreaks by collecting data from a network of clinics that serve international travelers. Human migration is complex and challenging in the context of disease emergence and spread, says Cetron. When it comes to germs, he notes, travelers are essentially sampling the world.

Networks allow much surveillance to be done from afar, but if a disease is particularly worrisome or complex, Cetron will dispatch a field team.

Among the newsworthy epidemics he and his staff have investigated are the H1N1 influenza pandemic of 2009, Ebola outbreaks from 2014 to the present, and the 2015 Zika virus outbreak.

You need to have a global surveillance network that provides eyes and ears and is constantly taking the pulse of whats happening out there in a world that is highly mobile and interconnected, he says. Those networks are much bigger, more robust, and more enduring than what any one individual can do alone.

Follow this link:
Research at the ends of the earth - AAMC